| FAQ/Help |
| Calendar |
| Search |
| Today's Posts |
06-14-2010, 11:02 PM
|
#1 | ||
|
|||
|
Member
|
* Phytopharm gets FDA go-ahead for Phase II trial of Cogane
* Oxford BioMedica reports positive two-year ProSavin data * Phytopharm's shares up 10 pct, Oxford gives up gains http://www.reuters.com/article/idUSLDE65D0OF20100614 We can only wait and hope but not count on it unfortunately. Imad |
||
|
 Reply With Quote
|
|
06-15-2010, 05:27 AM
|
#2 | ||
|
|||
|
Member
|
I called them up to ask about participating in the trial and they said to call back in a few months.
Trixiedee |
||
|
|
Reply With Quote
|
| Reply |
|
|
Similar Threads
|
||||
| Thread | Forum | |||
| Phytopharm: Commencement of Clinical Study of Cogane in Patients with PD | Parkinson's Disease Clinical Trials | |||
| Plant-based Parkingson’s drug Cogane enters clinical studies | Parkinson's Disease | |||
| cogane completes Phase 1 in USA | Parkinson's Disease | |||
| MJF funded trials of "cogane" --oral drug which increases GDNF | Parkinson's Disease | |||
| Trophos Successfully Completes Phase Ib ALS Clinical Trials for TRO19622, a Novel Com | ALS | |||
Phase II clinical trials of Cogane
Linear Mode
